 |
|
| Blog results | Results 1 - 10 of about 13,303 for diclofenac sodium. (0.28 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Dr. Jarret Morrow's Arthritis Research Updates - http://arthritisresearchupdates.blogspot.com/ | |
| 3 Dec 2009 Voltaren Gel (diclofenac sodium topical gel) 1% - Hepatic Effects Labeling Changes. December 4, 2009. Audience: Rheumatological healthcare professionals, pharmacists. Endo, Novartis and FDA notified healthcare professionals of revisions ... Drugs.com - FDA MedWatch Alerts - http://www.drugs.com/fda_alerts.html - References |
| 12 Dec 2009 According to a study published December 2009 in Seminars in Arthritis and Rheumatism, 492 adults aged 35 years or older with symptomatic knee osteoarthritis for more than 6 months were randomly assigned diclofenac sodium gel or a ... About.com Osteoarthritis - http://osteoarthritis.about.com/b/ [ More results from About.com Osteoarthritis ] |
| 7 Dec 2009 The FDA has notified healthcare professionals in the US of revisions to the 'hepatic effects' section of the prescribing information for diclofenac sodium topical gel (Voltaren® Gel), to include new warnings and precautions about the ... NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/ |
| 10 Dec 2009 The prescribing information for all diclofenac-containing products in the US has been updated at the request of the US FDA. The update pertains to expanded warnings and precautions on the risk of elevations in liver enzymes during ... Scrip News - Home - RSS - http://www.scripnews.com/home/ |
| 7 Dec 2009 by Mark Zamora Voltaren Gel (diclofenac sodium topical gel) 1% - Hepatic Effects Labeling Changes. Endo, Novartis and FDA notified healthcare professionals of revisions to the Hepatic Effects section of the prescribing information to add new warnings ... A Georgia Lawyer - http://ageorgialawyer.blogspot.com/ - References |
| 5 Dec 2009 FDA alerts doctors to adverse effects of diclofenac sodium. foodconsumer.org - http://www.foodconsumer.org/newsite/ |
| 7 Dec 2009 by Sandi Pniauskas FDA Alert: Voltaren Gel (diclofenac sodium topical gel) 1% - Hepatic Effects Labeling Changes. Posted by Sandi Pniauskas at Tuesday, December 08, 2009. 0 comments: Post a Comment. Newer Post Older Post Home. Subscribe to: Post Comments ... OVARIAN CANCER and US - http://ovariancancerandus.blogspot.com/ |
| 11 Dec 2009 by Tom Lamb On December 4, 2009 the FDA issued this MedWatch alert, "Voltaren Gel (diclofenac sodium topical gel) 1% - Hepatic Effects Labeling Changes", which provided news about an emerging drug safety issue concerning all products containing ... Drug Injury Watch - http://www.drug-injury.com/druginjurycom/ |
| 3 Dec 2009 by admin Voltaren Gel (diclofenac sodium topical gel) 1% – Hepatic Effects Labeling Changes. Audience: Rheumatological healthcare professionals, pharmacists. Endo, Novartis and FDA notified healthcare professionals of revisions to the Hepatic ... Attorney At Law - http://www.attorneyatlaw.com/ [ More results from Attorney At Law ] |
| 18 Dec 2009 by salud equitativa Visicol (sodium phosphate dybasic anhydrous and sodium phosphate monobasic monohydrate) [2009 version] Vivactil (protriptyline hydrochloride) [2007 version] Voltaren (diclofenac sodium) [2009 version] Votrient (pazopanib hydrochloride) ... CIENCIASMEDICASNEWS - http://elbiruniblogspotcom.blogspot.com/ - References [ More results from CIENCIASMEDICASNEWS ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
